These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17057811)

  • 1. Quality of life in patients with Graves ophthalmopathy.
    Yeatts RP
    Trans Am Ophthalmol Soc; 2005; 103():368-411. PubMed ID: 17057811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between quality of life, cognition, and thyroid status in Graves' disease.
    Riguetto CM; Neto AM; Tambascia MA; Zantut-Wittmann DE
    Endocrine; 2019 Jan; 63(1):87-93. PubMed ID: 30173328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision-related quality of life tends to be more severely impaired in patients with dysthyroid optic neuropathy.
    Du Y; Ye H; Li K; Xiao X; Chen R; He JF; Yang H
    Curr Eye Res; 2014 May; 39(5):532-6. PubMed ID: 24215175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
    Iacobæus L; Sahlin S
    Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in Graves' ophthalmopathy.
    Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):359-70. PubMed ID: 22632371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease.
    Fayers T; Dolman PJ
    Br J Ophthalmol; 2011 Dec; 95(12):1670-4. PubMed ID: 21951566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of quality of life in patients with Graves orbitopathy and its influencing factors].
    Weng CY; Li ZF; Hu SD; Luo YS; Feng XT; Zhong Q; Zhang Q; Shen J
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):577-583. PubMed ID: 31365979
    [No Abstract]   [Full Text] [Related]  

  • 9. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
    Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
    Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of quality of life and depression in Korean patients with Graves' ophthalmopathy.
    Lee H; Roh HS; Yoon JS; Lee SY
    Korean J Ophthalmol; 2010 Apr; 24(2):65-72. PubMed ID: 20379454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life in patients with orbitopathy - single center experience].
    Charążka B; Suligowska A; Komorowski J; Siejka A
    Pol Merkur Lekarski; 2018 Jun; 44(264):272-275. PubMed ID: 30057393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
    Smith TJ; Cockerham K; Barretto N; Hirst A; Oliver L; Enstone A; Brandolini G; Taylor SD; Holt RJ
    Endocr Pract; 2024 May; 30(5):470-475. PubMed ID: 38341128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry Eye Syndrome in Non-Exophthalmic Graves' Disease.
    Bruscolini A; Abbouda A; Locuratolo N; Restivo L; Trimboli P; Romanelli F
    Semin Ophthalmol; 2015; 30(5-6):372-6. PubMed ID: 24460515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
    Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
    Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument.
    Gerding MN; Terwee CB; Dekker FW; Koornneef L; Prummel MF; Wiersinga WM
    Thyroid; 1997 Dec; 7(6):885-9. PubMed ID: 9459632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy.
    Lin IC; Lee CC; Liao SL
    J Formos Med Assoc; 2015 Nov; 114(11):1047-54. PubMed ID: 24434244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial factors in subjects with thyroid-associated ophthalmopathy.
    Kahaly GJ; Hardt J; Petrak F; Egle UT
    Thyroid; 2002 Mar; 12(3):237-9. PubMed ID: 11952046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in a german graves orbitopathy population.
    Ponto KA; Hommel G; Pitz S; Elflein H; Pfeiffer N; Kahaly GJ
    Am J Ophthalmol; 2011 Sep; 152(3):483-490.e1. PubMed ID: 21676374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
    Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
    Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients.
    Son BJ; Lee SY; Yoon JS
    Can J Ophthalmol; 2014 Apr; 49(2):167-73. PubMed ID: 24767223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.